Exploratory Study of NS-089/NCNP-02 in DMD

NCT04129294 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Duchenne Muscular Dystrophy

Interventions

DRUG: NS-089/NCNP-02

Sponsor

National Center of Neurology and Psychiatry, Japan

Collaborators

[object Object]